Search Results - "Skotnicki, A"

Radiation Necrosis of the Lateral Skull Base and Temporal Bone by Herr, Marc W, Vincent, Aurora G, Skotnicki, Meghan A, Ducic, Yadranko, Manolidis, Spiros

“…Radiation therapy plays a critical role in the treatment of malignancies involving the head and neck. Although the therapeutic effects of ionizing radiation…”
Get full text

Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL by Giebel, S, Stella-Holowiecka, B, Krawczyk-Kulis, M, Gökbuget, N, Hoelzer, D, Doubek, M, Mayer, J, Piatkowska-Jakubas, B, Skotnicki, A B, Dombret, H, Ribera, J M, Piccaluga, P P, Czerw, T, Kyrcz-Krzemien, S, Holowiecki, J

“…The role of autologous hematopoietic SCT (autoHSCT) in the treatment of high-risk (HR) adult ALL is controversial. In this study, we retrospectively analyzed…”
Get full text

Hospital outbreak of vancomycin-resistant enterococci caused by a single clone of Enterococcus raffinosus and several clones of Enterococcus faecium by Kawalec, M., Kedzierska, J., Gajda, A., Sadowy, E., Wegrzyn, J., Naser, S., Skotnicki, A.B., Gniadkowski, M., Hryniewicz, W.

“…A mixed outbreak caused by vancomycin-resistant Enterococcus raffinosus and Enterococcus faecium carrying the vanA gene was analysed. The outbreak occurred in…”
Get full text

Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial by Robak, Tadeusz, Bloński, Jerzy Z., Kasznicki, Marek, Blasińska-Morawiec, Maria, Krykowski, Euzebiusz, Dmoszyńska, Anna, Mrugala-Śpiewak, Halina, Skotnicki, Aleksander B., Nowak, Wieslaw, Konopka, Lech, Ceglarek, Bernadeta, Maj, Stanislaw, Dwilewicz-Trojaczek, Jadwiga, Hellmann, Andrzej, Urasiński, Ignacy, Zdziarska, Barbara, Kotlarek-Haus, Sabina, Potoczek, Stanislaw, Grieb, Pawel

“…The efficacy and toxicity of cladribine (2-CdA) + prednisone (P) versus chlorambucil (Chl) + P were compared in previously untreated patients with progressive…”
Get full text

The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant by NASILOWSKA-ADAMSKA, B, RZEPECKI, P, DUDA, D, SZYDLO, R, HALABURDA, K, SZCZEPINSKI, A, LANGE, A, HELLMAN, A, ROBAK, T, SKOTNICKI, A, JEDRZEJCZAK, W. W, WALEWSKI, J, MANKO, J, HOLOWIECKI, J, KOMARNICKI, M, DMOSZYNSKA, A, WARZOCHA, K, MARIANSKA, B, CZYZ, A, MARKIEWICZ, M, FEDEROWICZ, I, TOMASZEWSKA, A, PIATKOWSKA-JAKUBAS, B, WRZESIEN-KUS, A, BIENIASZEWSKA, M

“…In this multicenter study, we assessed the use of palifermin (recombinant human-keratinocyte growth factor 1) in the prevention of oral mucositis (OM) and…”
Get full text

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study by HOLOWIECKI, J, GROSICKI, S, ZDZIARSKA, B, DMOSZYNSKA, A, MARIANSKA, B, PLUTA, A, ZAWILSKA, K, KOMARNICKI, M, KLOCZKO, J, SULEK, K, HAUS, O, STELLA-HOLOWIECKA, B, ROBAK, T, BARAN, W, JAKUBAS, B, PALUSZEWSKA, M, WIERZBOWSKA, A, KIELBINSKI, M, JAGODA, K, KYRCZ-KRZEMIEN, S, GIEBEL, S, HELLMANN, A, SKOTNICKI, A, JEDRZEJCZAK, W. W, KONOPKA, L, KULICZKOWSKI, K

“…To assess the efficacy of an original DAC-7 regimen: daunorubicine (DNR) 60 mg/m2/day, days 1-3; cytarabine (AraC) 200 mg/m2/day, days 1-7; cladribine (2-CdA)…”
Get full text

Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine® in previously treated patients with severe haemophilia B by SERBAN, M., SKOTNICKI, A. B., COLOVIC, M., JINCA, C., KLUKOWSKA, A., LAGUNA, P., WOLF, D. M.

“…Plasma‐derived factor IX (FIX) concentrate remains an important choice for replacement therapy in haemophilia B patients. Haemonine® is a high purity…”
Get full text

Cladribine with or without prednisone in the treatment of previously treated and untreated B‐cell chronic lymphocytic leukaemia — updated results of the multicentre study of 378 patients by ROBAK, T, BLONSKI, J. Z, TOMASZEWSKA, A, HELLMANN, A, LEWANDOWSKI, K, KULICZKOWSKI, K, POTOCZEK, S, ZDZIARSKA, B, HANSZ, J, KROLL, R, KOMARNICKI, M, HOŁOWIECKI, J, KASZNICKI, M, GRIEB, P, KONOPKA, L, CEGLAREK, B, DMOSZYNSK, A, SOROKA-WOJTASZKO, M, SKOTNICKI, A. B, NOWAK, W, DWILEWICZ-TROJACZEK, J

“…Between January 1992 and January 1999, we treated 378 B‐chronic lymphocytic leukaemia (CLL) patients with cladribine (2‐CdA), and 255 of the patients were also…”
Get full text

Thalidomide treatment of resistant or relapsed multiple myeloma patients by Hus, M, Dmoszynska, A, Soroka-Wojtaszko, M, Jawniak, D, Legiec, W, Ciepnuch, H, Hellmann, A, Wolska-Smolen, T, Skotnicki, A, Manko, J, Polish Multiple Myeloma Study Group

“…Department of Hematology University Medical School, Lublin, Poland. BACKGROUND AND OBJECTIVES: Thalidomide is currently used as a very promising drug in…”
Get full text

Importance of Parenteral Nutrition in Patients Undergoing Hemopoietic Stem Cell Transplantation Procedures in the Autologous System by Skop, A., Kolarzyk, Emilia, Skotnicki, A.B.

“…Objective: The aim of this study was to assess the frequency of parenteral nutrition and to compare the impact of parenteral and oral feeding on the nutrition…”
Get full text

Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia by ROBAK, T, BŁONSKI, J. Z, D.WOŁOWIEC, STELLA-HOŁOWIECKA, B, SKOTNICKI, A. B, NOWAK, W, MOSKWA-SROKA, B, DMOSZYNSKA, A, CALBECKA, M, KASZNICKI, M, GORA-TYBOR, J, DWILEWICZ-TROJACZEK, J, BOGURADZKI, P, KONOPKA, L, CEGLAREK, B, SUŁEK, J, KULICZKOWSKI, K

“…The objective of the study was to determine the effectiveness and the toxicity of a combined chemotherapy consisting of cladribine (2-CdA), mitoxantrone and…”
Get full text

Severe bleeding diathesis associated with moderate thrombocytopenia - diagnostic workup of seven family members with type 2B von Willebrand's disease by ZDZIARSKA, J., IWANIEC, T., SKOTNICKI, A. B., MUSIAŁ, J., SCHNEPPENHEIM, R., BUDDE, U., KENTOUCHE, K.

Get full text

An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma by HUS, I, DMOSZYNSKA, A, SULEK, K, ROBAK, T, KONOPKA, L, KLOCZKO, J, MANKO, J, HUS, M, JAWNIAK, D, SOROKA-WOJTASZKO, M, HELLMANN, A, CIEPLUCH, H, SKOTNICKI, A, WOLSKA-SMOLEN, T

“…The aim of this study was to assess the prognostic value of pretreatment clinical and laboratory parameters in refractory or relapsed multiple myeloma (MM)…”
Get full text

Laparoscopic removal of retroperitoneal accessory spleen in patient with relapsing idiopathic thrombocytopenic purpura 30 years after classical splenectomy by Budzynski, A, Bobrzyński, A, Sacha, T, Skotnicki, A

“…The clinical success of therapeutic splenectomy for idiopathic thrombocytopenic purpura depends on the complete removal of all functional splenic tissue. Among…”
Get full text

Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients by Czyż, J., Dziadziuszko, R., Knopińska-Postuszuy, W., Hellmann, A., Kachel, Ł., Hołowiecki, J., Goździk, J., Hansz, J., Avigdor, A., Nagler, A., Osowiecki, M., Walewski, J., Mensah, P., Jurczak, W., Skotnicki, A., Sędzimirska, M., Lange, A., Sawicki, W., Sułek, K., Wach, M., Dmoszyńska, A., Kuś, A., Robak, T., Warzocha, K.

“…Background: The reported probability of survival of patients with Hodgkin's disease (HD) following high-dose chemotherapy with autologous stem cell…”
Get full text

Elongation index of erythrocytes, study of activity of chosen erythrocyte enzymes, and the levels of glutathione, malonyldialdehyde in polycythemia vera (PV) by Dąbrowski, Z, Dybowicz, A J, Marchewka, A, Teległów, A, Skotnicki, A, Zduńczyk, A, Aleksander, P, Filar-Mierzwa, K

“…The principal aim of the study was to investigate rheological properties of erythrocytes obtained from patients admitted to the clinic, and diagnosed with…”
Get more information

2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger by ROBAK, T, BŁONSKI, J. Z, URBANSKA-RYS, H, BŁASINSKA-MORAWIEC, M, SKOTNICKI, A. B

“…The aim of the study was to determine the effectiveness of 2-chlorodeoxyadenosine (2-CdA) administered in 2-h i.v. infusions in the treatment of B cell chronic…”
Get full text

2-Chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland by Robak, T., Błasińska-Morawiec, M., Błasiński, J., Hellmann, A., Hałaburda, K., Konopka, L., Kotlarek-Haus, S., Potoczek, S., Hansz, J., Dmoszyn̊ska, A., Urasiński, I., Zdziarska, B., Dwilewicz-Trojaczek, J., Hołowiecki, J., Skotnicki, A. B.

“…: Between January 1991 and December 1997, 103 patients, 97 with typical hairy cell leukemia (HCL) and 6 with HCL‐variant (HCL‐V) were treated with…”
Get full text

A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG) by Wrzesień-Kuś, A., Robak, T., Lech-Marańda, E., Wierzbowska, A., Dmoszyńska, A., Kowal, M., Hołowiecki, J., Kyrcz-Krzemień, S., Grosicki, S., Maj, S., Hellmann, A., Skotnicki, A., Je˛drzejczak, W., Kuliczkowski, K.

“…: Objectives: To evaluate the efficacy and toxicity of cladribine (2‐chlorodeoxyadenosine, 2‐CdA), cytarabine (Ara‐C), and granulocyte‐colony stimulating…”
Get full text

Selection of a Teicoplanin-Resistant Enterococcus faecium Mutant during an Outbreak Caused by Vancomycin-Resistant Enterococci with the VanB Phenotype by KAWALEC, Magdalena, GNIADKOWSKI, Marek, KEDZIERSKA, Jolanta, SKOTNICKI, Aleksander, FIETT, Janusz, HRYNIEWICZ, Waleria

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text